Clinical application value of metagenomic next-generation sequencing in the diagnosis of spinal infections and its impact on clinical outcomes

被引:19
|
作者
Zhang, Guang [1 ,3 ]
Zhang, Hongqi [1 ,3 ]
Hu, XiaoJiang [1 ,3 ]
Xu, Dongcheng [1 ,3 ]
Tang, Bo [1 ,3 ]
Tang, Mingxing [1 ,3 ]
Liu, Shaohua [1 ,3 ]
Li, Yanbing [2 ,3 ]
Xu, Wen [4 ]
Guo, Chaofeng [1 ,3 ]
Gao, Qile [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Spine Surg & Orthopaed, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[4] Guangzhou Sagene Biotechnol Co Ltd, Dept Sci Affaires, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
metagenomic next-generation sequencing; diagnosis; spinal infection; traditional; prognosis; VERTEBRAL OSTEOMYELITIS; SENSITIVITY;
D O I
10.3389/fcimb.2023.1076525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study aimed to evaluate the impact of precise treatment administered according to the results of metagenomic next-generation sequencing (mNGS) on the clinical outcomes of patients with spinal infections. In this multicenter retrospective study, the clinical data of 158 patients with spinal infections who were admitted to Xiangya Hospital Central South University, Xiangya Boai Rehabilitation Hospital, The First Hospital of Changsha, and Hunan Chest Hospital from 2017 to 2022 were reviewed. Among these 158 patients, 80 patients were treated with targeted antibiotics according to the mNGS results and were assigned to the targeted medicine (TM) group. The remaining 78 patients with negative mNGS results and those without mNGS and negative microbial culture results were treated with empirical antibiotics and assigned to the empirical drug (EM) group. The impact of targeted antibiotics based on the mNGS results on the clinical outcomes of patients with spinal infections in the two groups was analyzed. The positive rate of mNGS for diagnosing spinal infections was significantly higher than that of microbiological culture (X (2)=83.92, P<0.001), procalcitonin (X (2)=44.34, P<0.001), white blood cells (X (2)=89.21, P < 0.001), and IGRAs (Interferon-gamma Release Tests) (X (2) = 41.50, P < 0.001). After surgery, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) showed a decreasing trend in the patients with spinal infections in both the TM and EM groups. The decrease in CRP was more obvious in the TM group than in the EM group at 7, 14 days, 3, and 6 months after surgery (P<0.05). The decrease in ESR was also significantly obvious in the TM group compared with the EM group at 1 and 6 months after surgery (P<0.05). The time taken for CRP and ESR to return to normal in the TM group was significantly shorter than that in the EM group (P<0.05). There was no significant difference in the incidence of poor postoperative outcomes between the two groups. The positive rate of mNGS for the diagnosis of spinal infection is significantly higher than that of traditional detection methods. The use of targeted antibiotics based on mNGS results could enable patients with spinal infections to achieve a faster clinical cure.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Clinical value of macrogenome next-generation sequencing on infections
    Han, Benfa
    Zhang, Xiaoli
    Li, Xiuxi
    Chen, Mei
    Ma, Yanlin
    Zhang, Yunxia
    Huo, Song
    OPEN LIFE SCIENCES, 2024, 19 (01):
  • [12] Next-generation sequencing and its clinical application
    Dahui Qin
    Cancer Biology & Medicine, 2019, (01) : 4 - 10
  • [13] Next-generation sequencing and its clinical application
    Qin, Dahui
    CANCER BIOLOGY & MEDICINE, 2019, 16 (01) : 4 - 10
  • [14] Next-generation sequencing and its clinical application
    Dahui Qin
    Cancer Biology & Medicine, 2019, 16 (01) : 4 - 10
  • [15] Metagenomic next-generation sequencing in clinical microbiology
    Jacob, Jobin John
    Veeraraghavan, Balaji
    Vasudevan, Karthick
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 37 (02) : 133 - 140
  • [16] Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges
    Su, LingHui David
    Chiu, Charles Y.
    Gaston, David
    Hogan, Catherine A.
    Miller, Steve
    Simon, Dennis W.
    Thakur, Kiran T.
    Yang, Shangxin
    Piantadosi, Anne
    MOLECULAR DIAGNOSIS & THERAPY, 2024, 28 (05) : 513 - 523
  • [17] The Clinical Value of Metagenomic Next-Generation Sequencing in Pneumocystis jirovecii Pneumonia
    Huang, Meng-Qi
    Zheng, Ting -Ting
    Wang, Xiao-Rong
    Xiang, Fei
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 69 - 80
  • [18] Clinical Value of Metagenomic Next-Generation Sequencing in Immunocompromised Patients with Sepsis
    Cheng, Zheng
    Yu, Feng
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [19] Pathogenic Detection by Metagenomic Next-generation Sequencing in Spinal Infections
    Yin, Chuqiang
    Cong, Yanan
    Wang, Huafeng
    Wang, Dechun
    Yang, Xizhong
    Wang, Xuesong
    Wang, Ting
    SPINE, 2025, 50 (04) : E70 - E75
  • [20] Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Meningitis and Encephalitis
    Wilson, Michael R.
    Sample, Hannah A.
    Zorn, Kelsey C.
    Naccache, Sarnia N.
    Miller, Steve
    Chiu, Charles Y.
    ANNALS OF NEUROLOGY, 2018, 84 : S110 - S110